Australasian Myeloma Research Consortium (AMaRC)
@MyelomaAmarc
Followers
430
Following
415
Media
110
Statuses
379
We are part of a haematology network based in ANZ that aims to trial Phase I/II treatment regimes, biologics & drug products for #Myeloma. #CancerResearch #MMsm
Prahran, Victoria, Australia
Joined October 2019
ZEPFHR-MM (Tec/Tal) is now recruiting at our first site in Queensland @pahospital. This study is a world-first multicentre phase II platform study exploring the use of different novel therapies in treating functional high-risk multiple myeloma. More info:
0
7
11
We are thrilled to report @Austin_Health is now recruiting to ZEPFHR Domain 1 for patients with #FunctionalHighRisk #MultipleMyeloma. This domain is one of the first IITs using the combination of bi-specific T-cell engaging antibodies teclistamab & talquetamab. @ONJCancerCentre
1
0
0
We now have an additional 4 sites recruiting to DSA1 (Tec/Tal) of the ZEPFHR-MM platform study!. Concord Hospital (@SydneyLHD), @PeterMacCC, @BarwonHealth, & Box Hill Hospital (@easternhealthau) are all actively recruiting. More new site announcements coming soon!
1
0
3
Our 1st patient has been recruited at @AlfredHealth.for ZEPFHR-MM #PlatformStudy Domain 1!. This domain will use the combination of teclistamab and talquetemab to treat patients with #FunctionalHighRisk #MultipleMyeloma. More info:
0
0
3
Our first Dara@Home patient has officially been registered at @PeterMacCC!. Dara@Home will assess the feasibility and effectiveness of daratumumab self-administration at home for patients with relapsed #MultipleMyeloma . More info: #mmsm #cancerresearch
1
0
1
We are thrilled to announce that Domain 1 (Tec/Tal) of ZEPFHR-MM is now recruiting at @AlfredHealth! . ZEPFHR is a world 1st multi-centre phase II #PlatformStudy exploring different novel therapies treating #FunctionalHighRisk #myeloma. More info: #mmsm
0
0
0
Dara@Home is now available at @AlfredHealth!. More info: #myeloma #multiplemyeloma #mmsm #cancerresearch #haematology #oncology #clinicaltrials #RRMM
0
1
4
🚨NEW STUDY🚨. Dara@Home is officially open for recruitment at @PeterMacCC!. The study will assess feasibility & effectiveness of a program enabling #MM patients who have #relapsed after 1L therapy to self-administer #daratumumab at home. More Info: #MMSM
1
0
1
March is #MyelomaActionMonth. Multiple myeloma is the 2nd most common blood cancer worldwide yet awareness remains low.
0
0
1
AMaRC investigators Prof. Joy Ho (Royal Prince Alfred, @SydneyLHD) and A/Prof, John Reynolds (@AlfredHealth) were invited faculty members for the @ASH_hematology Clinical Research Training Institute in Asia Pacific in Japan last week. More info:
0
0
1
RT @ALLGtrials: Congratulations to ALLG members for their poster presentations today at ASH 2024 on the trial results of ALLG MDS05/D1 MYDA….
0
4
0
Dr Sueh-li Lim & Prof Andrew Spencer from AMaRC presenting initial results from the FRAIL-M study for patients with #TINDMM at #ASH24. #allgtrials #myeloma #multiplemyeloma #mmsm #cancerresearch #haematology #oncology #clinicaltrials #frailty. More info:
0
0
5
RT @gjmccaughan: Looking forward to Dr Sueh-Li Liu and Professor Spencer presenting @MyelomaAmarc @ALLGtrials FRAIL-M at the poster session….
ashpublications.org
Disclosures. Lim:Janssen: Honoraria. Reynolds:Telethon Kids Institute (Australia): Membership on an entity's Board of Directors or advisory committees; San
0
1
0
RT @gjmccaughan: Dr Sueh-Li Lim & Professor Andrew Spencer present initial results from the @MyelomaAmarc @ALLGtrials FRAIL-M trial. This f….
0
1
0
RT @MMKingT: @MyelomaAmarc Prof Andrew Spencer @hsanz_org_au follows @gjmccaughan presenting decade of #MRDR 🇦🇺🦘data
0
1
0
RIDDLE-M-X for transplant eligible #NDMM is now available at Canberra Hospital! @ACT_CHS. This study uses a risk & response adaptation approach. More info: #NDTEMM #myeloma #multiplemyeloma #mmsm #cancerresearch #haematology #oncology #clinicaltrials
0
0
0
The IBIS study for patients with #FunctionalHighRiskMM is now actively recruiting at Sunshine Hospital! @western_health . More info: #FHRMM #RRMM #myeloma #multiplemyeloma #mmsm #cancerresearch #haematology #oncology #clinicaltrials
0
1
2
RT @erica_m_wood: Everyone is welcome at the annual Aust/NZ Myeloma and Related Diseases Registry breakfast meeting. Join us this year at B….
0
2
0